Solana (HSDT)
Nasdaq Market Open
Solana Company is a publicly traded digital asset treasury company focused on building exposure to Solana, the blockchain network’s native token, SOL. Rather than operating as a conventional technology business with product revenue as its central driver, the company’s strategy is to use its public market listing and access to capital markets to accumulate and manage SOL holdings over time.
The company was established in partnership with Pantera and Summer Capital, linking it to investors with experience in digital assets and growth-stage technology markets. Its stated objective is to increase SOL per share, a metric that reflects how much Solana exposure each share represents after considering corporate financing, treasury management, and operating decisions.
Solana is known for its high-throughput blockchain infrastructure and is used across areas such as decentralised finance, stablecoin transfers, tokenised assets, gaming, and consumer crypto applications. As a result, Solana Company’s investment case is closely tied to market demand for SOL, the development of the Solana ecosystem, and broader sentiment toward crypto assets.
The business may also seek to enhance returns through on-chain activity and capital allocation decisions, although these strategies can introduce operational, market, and regulatory risks. For equity investors, the stock offers an indirect way to gain exposure to SOL through a listed company structure. Its performance can therefore differ from holding the token directly because share issuance, corporate expenses, premiums or discounts to net asset value, and market liquidity can all influence returns.
Last updated
- Market Cap
- 86.41M
- P/E
- —
- P/FCF
- —
- P/S
- 9.01
- Enterprise Value
- 82.83M
- Sector
- Health Care
- Industry
- Electromedical and Electrotherapeutic Apparatus
- Address
- 642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA, 18940
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know
Helius Medical Technologies to Present at NobleCon19 Annual Conference
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 86.41M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 82.83M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.44
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 9.01
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -4.39
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 8.64
- EPS
- -2.34
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -69.15%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -68.18%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 9.9
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 9.9
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.56
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 270.56K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 1.48
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 3.62M | 5.23M | 697K | 43K | 49K |
| Gross profit | 3.44M | 5.05M | 594K | -53K | -72K |
| Operating income | -1.75M | -8.88M | -4.91M | -3.32M | -4.01M |
| EBITDA | -1.75M | -8.88M | -4.91M | -3.31M | -4.01M |
| Net income | -99.8M | 325.55M | -352.77M | -9.83M | -3.84M |
| Basic EPS | -1.3 | 88.29 | -32.89 | -79.73 | -382.29 |
| Diluted EPS | -1.3 | 88.29 | -32.89 | -79.73 | -382.29 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 200.71M | 303.93M | 475.92M | 7.89M | 3.48M |
| Total liabilities | 2.81M | 3.02M | 628.31M | 1.87M | 4.05M |
| Total equity | 197.9M | 300.91M | -152.39M | 6.03M | -563K |
| Cash & equivalents | 4.4M | 7.28M | 124.05M | 6.08M | 1.11M |
| Current assets | 27.84M | 31.16M | 125.66M | 7.8M | 3.39M |
| Current liabilities | 2.81M | 3.02M | 3.14M | 1.81M | 2M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -4.83M | -6.18M | -4.04M | -2.76M | -3.54M |
| Investing cash flow | 5.47M | -159.15M | -267.38M | — | — |
| Financing cash flow | -3.52M | 48.56M | 389.4M | 7.73M | 3.56M |
| Change in cash | -2.89M | -116.77M | 117.97M | 4.97M | 21K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — Solana Co | View Filing | |
| edgar index | 424B5 — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4/A — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | SCHEDULE 13D/A — Solana Co | View Filing | |
| edgar index | 4/A — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 3 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 3 | Form 3 — Fusion Summer Ltd | View Filing | |
| form 3 | Form 3 — Fusion Summer Ltd | View Filing | |
| form 4 | Form 4 — STRAW EDWARD M | View Filing | |
| form 4 | Form 4 — STRAW EDWARD M | View Filing | |
| form 4 | Form 4 — Walter Blane | View Filing | |
| form 4 | Form 4 — Walter Blane | View Filing | |
| form 4 | Form 4 — Lee Michel Kai Tai | View Filing | |
| form 4 | Form 4 — Lee Michel Kai Tai | View Filing | |
| form 4 | Form 4 — Mello Sergio | View Filing | |
| form 4 | Form 4 — Mello Sergio | View Filing | |
| edgar index | DEFA14A — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| edgar index | 10-Q — Solana Co | View Filing | |
| edgar index | SCHEDULE 13G/A — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | SCHEDULE 13D/A — Solana Co | View Filing | |
| form 4 | Form 4 — Fusion Summer Ltd | View Filing | |
| form 4 | Form 4 — Chee Choon Wee | View Filing | |
| form 4 | Form 4 — Chee Choon Wee | View Filing | |
| edgar index | SCHEDULE 13G/A — Solana Co | View Filing | |
| edgar index | DEFA14A — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| edgar index | 424B5 — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | ARS — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | EFFECT — Solana Co | View Filing | |
| edgar index | EFFECT — Solana Co | View Filing | |
| edgar index | 3 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| edgar index | 4 — Solana Co | View Filing | |
| form 4 | Form 4 — STRAW EDWARD M | View Filing | |
| form 4 | Form 4 — STRAW EDWARD M | View Filing | |
| form 4 | Form 4 — STRAW EDWARD M | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — Walter Blane | View Filing | |
| form 4 | Form 4 — Walter Blane | View Filing | |
| form 4 | Form 4 — Walter Blane | View Filing | |
| form 4 | Form 4 — Perkins Sherrie L | View Filing | |
| form 4 | Form 4 — Perkins Sherrie L | View Filing | |
| edgar index | POSASR — Solana Co | View Filing | |
| edgar index | POSASR — Solana Co | View Filing | |
| edgar index | SCHEDULE 13G — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Solana Co | View Filing | |
| edgar index | SCHEDULE 13G/A — Solana Co | View Filing | |
| edgar index | POSASR — Solana Co | View Filing | |
| edgar index | 8-K — Solana Co | View Filing | |
| edgar index | 10-Q — Solana Co | View Filing |